Skip to main content

Month: January 2024

Semantix Provides Update Regarding Nasdaq Minimum Bid Price Compliance

SÃO PAULO, Brazil, Jan. 05, 2024 (GLOBE NEWSWIRE) — Semantix, Inc. (NASDAQ: STIX), a leading Latin American enterprise AI platform and applications provider, today announced that on January 2, 2024 it received a written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with the minimum bid price requirement of US$1.00 per share set forth in Nasdaq Rules, based on the closing bid price of the Company’s Ordinary Shares for the last 34 consecutive business days from November 10, 2023 to December 29, 2023. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided with an initial 180 calendar days period, ending on July 1, 2024, to regain compliance with the Listing Rules. To regain compliance, the Company’s Ordinary Shares must have a closing bid price of at least...

Continue reading

Triumph Financial Announces Schedule for Fourth Quarter 2023 Earnings Release and Conference Call

DALLAS, Jan. 05, 2024 (GLOBE NEWSWIRE) — Triumph Financial, Inc. (Nasdaq: TFIN) today announced that it expects to release its fourth quarter financial results and management commentary after the market closes on Tuesday, January 23, 2024. Upon filing, the financial results and commentary will be available on the Company’s website at tfin.com. Aaron P. Graft, Vice Chairman and CEO, and Brad Voss, CFO, will review the financial results in a conference call with investors and analysts beginning at 9:30 a.m. central time on Wednesday, January 24, 2024. The live video conference option may be accessed directly through this link, https://triumph-financial-inc-earnings-q4fy23.open-exchange.net or via the Company’s website at tfin.com through the News & Events, Events & Presentations links. Alternatively, a live conference...

Continue reading

BioCryst Announces Preliminary Full Year 2023 ORLADEYO® (berotralstat) Net Revenue of $325 Million, Provides 2024 Guidance and Accelerated Path to Profitability

—ORLADEYO preliminary 2023 full year net revenue of $325 million (+29 percent y-o-y)— —ORLADEYO net revenue expected to be between $380-$400 million in 2024, on trajectory for $1 billion in peak sales— —Operating expenses expected to remain flat ($365-$375 million) in 2024— —Company expects operating profit in 2024, approaching positive EPS and positive cash flow in 2H 2025— RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2024 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced preliminary, unaudited ORLADEYO® (berotralstat) net revenue for the fourth quarter and full year 2023. The company also provided guidance for full year 2024 ORLADEYO net revenue, full year 2024 operating expenses, expected peak ORLADEYO sales and an accelerated path to profitability. “After three years on the market, ORLADEYO continues...

Continue reading

ORYZON Announces Topline Results from Phase IIb PORTICO Study of Vafidemstat in Borderline Personality Disorder (BPD)

Company to host Conference Call and live Webcast on Sunday, January 7, 2024 at 5:30 pm PT. An executive summary of the data to be presented at the 7th Sachs Annual Neuroscience Innovation Forum, on January 7 at 3:30 pm PT, at the Marine’s Memorial Club in San Francisco (USA).Results across all efficacy endpoints consistently favored vafidemstat over placebo. Global Statistical Test (GST p-values) confirms consistent trend across efficacy endpoints The primary endpoints, improvement in Borderline Personality Disorder Checklist (BPDCL) and in agitation/aggression by the Clinical Global Impression – Severity Agitation/Aggression (CGI-S A/A), did not reach statistical significance Nominal statistical significance was achieved on the secondary endpoint Borderline Evaluation of Severity (BEST), an overall measure of BPD disease severity, at...

Continue reading

$15 Million Dividend Declared by Mutual Insurance Company of Arizona

PHOENIX, Jan. 05, 2024 (GLOBE NEWSWIRE) — The Mutual Insurance Company of Arizona® (MICA) announced today that its Board of Trustees has declared a dividend to its policyholders. A total of $15 million will be allocated among current members as of December 31, 2023, the record date. This dividend will be distributed in February 2024. The dividend represents approximately 18% of a policyholder’s 2023 annual premium for those members insured by MICA for a full three-year period ending on the December 31, 2023 record date. Members current as of the record date who were consecutively insured less than the full three-year period will receive a pro-rated amount. Additional information regarding the policyholder dividend distribution for each member will be available on the member portal at www.mica-insurance.com in early February 2024. “We...

Continue reading

Total number of voting rights and shares forming the share capital as at 31 December 2023

Nanterre, 5 January 2024 Total number of voting rights and shares forming the share capital (Article L. 233-8 II of the French Commercial Code and Article 223-16 ofthe General Regulation of the French Financial Markets Authority)__________________ Trading place: Euronext Paris Compartment: A ISIN code: FR0000121147 LEI code: 969500F0VMZLK2IULV85  Date   Number of shares   Total number of voting rights (theoretical) (1)      31 December 2023         197,089,340     211,067,019(1) In accordance with the provisions of Article 223-11 of the General Regulation of the French Financial Markets Authority, the total number of voting rights (theoretical) is calculated on the basis of all the shares to which voting rights are attached, including the shares deprived of voting rights. Inclusion in the bylaws of a clause that requires crossing...

Continue reading

Stingray and BYD Expand Partnership to Include Calm Radio in their EV Cars

MONTREAL, Jan. 05, 2024 (GLOBE NEWSWIRE) — Stingray (TSX: RAY.A; RAY.B), a leading music, media, and technology company, today announced the expansion of its global deal with BYD, the world’s leading manufacturer of new energy vehicles. Following the successful integration of Stingray Karaoke, BYD will now include the established Calm Radio app in their models sold across dozens of countries. This represents the first time that Calm Radio has been deployed across a leading EV OEM platform, showcasing Stingray’s commitment to revolutionizing the global in-car entertainment landscape with compelling content and features. Calm Radio offers a unique audio experience that enhances the driving journey with the power of relaxing content, including access to an extensive collection of calming music, podcasts, audiobooks and meditations,...

Continue reading

StoneCo Announces SCFI License

GEORGETOWN, Cayman Islands, Jan. 05, 2024 (GLOBE NEWSWIRE) — StoneCo Ltd. (Nasdaq: STNE; B3: STOC31) (“Stone” or the “Company”) today announced that it received from the Brazilian Central Bank (“BCB”) the “Financeira” License, organized as a Sociedade de Crédito, Financiamento e Investimento (SCFI). This license will enable StoneCo, through its subsidiaries, to develop and offer a range of new products, such as time deposits, which shall enhance and diversify the funding sources of the Company. About StoneCo StoneCo is a leading provider of financial technology and software solutions that empower merchants to conduct commerce seamlessly across multiple channels and help them grow their businesses. Forward-Looking Statements This press release contains “forward-looking statements” within the meaning of the “safe...

Continue reading

Medical Cannabis Market to Worth USD 60.04 Billion by 2030 | Skyquest Technology

Medical cannabis market is segmented on the basis of type, application. By type, the market is segmented into flower, edible, concentrates, others. By application, market is segmented into cancer, pain disorders, others. – Industry forecast 2023-2030 Westford,USA, Jan. 05, 2024 (GLOBE NEWSWIRE) — According to SkyQuest, the legalization of medical marijuana in numerous countries has ushered in a significant shift in how cannabis is cultivated and utilized in the medical cannabis market. One of the primary methods of ensuring a consistent supply of medical cannabis is domestic cultivation, which reduces the dependence on imports and helps generate substantial revenue through taxation. Get sample copy of this report: https://www.skyquestt.com/sample-request/medical-cannabis-market Browse in-depth TOC on the “Medical Cannabis...

Continue reading

Icelandair’s fleet renewal continues

Icelandair and SMBC have signed a long-term lease agreement for one Airbus A321LR aircraft scheduled to be delivered in the first quarter of 2026. This will be the fifth A321LR aircraft leased from SMBC. As previously announced, Icelandair signed a contract with Airbus for up to 25 Airbus A321XLR aircraft in July 2023 as well as a long-term lease agreement with SMBC for four new A321LR aircraft. The Airbus A321LR and XLR aircraft will be the future replacement of Icelandair’s fleet of Boeing 757s. Deliveries of the LR aircraft will begin in 2024, and XLR deliveries will start in 2029. Bogi Nils Bogason, Icelandair president and CEO: “We are very pleased to announce the lease of one more aircraft from our long-term partner SMBC Aviation Limited. We have already started entry into service for these efficient aircraft that will replace our...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.